The Asia Pacific Ureteroscopy Market would witness market growth of 6.0% CAGR during the forecast period (2022-2028).
Smaller kidney stones are more readily and successfully removed. Nevertheless, larger kidney stones are first divided into smaller pieces using high-frequency sound waves or electrical radiation (a procedure known as electrohydraulic lithotripsy), but laser is the most popular method. The removal of stones from the ureter and those near the bladder is also accomplished with success by ureteroscopy. The stone will be lithotripsy-fractured into tiny pieces after being forced back up the kidney.
The operation is carried out under spinal or general anesthesia to provide the patient's maximum comfort. A ureteroscope is inserted into the ureter or kidneys during this surgery via the urethra and bladder. In addition, theologist may employ X-ray scans with a contrast agent (dye) in the ureters to find the stone and rule out other abnormalities. The ureteroscope is a long, thin instrument with a tiny fiber optic camera attached to it used to view the ureters beyond the bladder. Once the stone has been discovered, it is either retrieved directly using a "stone basket" or broken into smaller pieces using a laser before being extracted using the basket.
China is also one of the countries that are aging the quickest in the world. By 2040, it is anticipated that the country's elderly population will be about 28%. This is a result of the country's declining fertility rate and increased life expectancy. This poses both a sizable challenge and a chance for socioeconomic and public health development. The region's growing elderly population increases the likelihood that certain illnesses would be common and, thus, the necessity for urethroscopy. In addition, the Japanese market has growth potential due to cutting-edge pain-relieving technology and treatments. As a result, there may be an increase in demand for minimally invasive medical procedures in the region, which would help the market there grow.
The China market dominated the Asia Pacific Ureteroscopy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.9 Million by 2028. The Japan market is estimated to grow a CAGR of 5.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.6% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Flexible, and Semi- Rigid. Based on Application, the market is segmented Urolithiasis, Urinary Stricture, Kidney Cancer, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Ureteroscopy Market is Projected to reach USD 1.1 Billion by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
By End User
By Product
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.